» Authors » Anupam Sachdeva

Anupam Sachdeva

Explore the profile of Anupam Sachdeva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 545
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Agarwala S, Kalra M, Sachdeva A, Anand K, Setia R
J Pediatr Hematol Oncol . 2024 Sep; 46(8):415-418. PMID: 39324966
Paroxysmal cold hemoglobinuria (PCH) is among the rarest forms of autoimmune hemolytic anemia, most often seen in young children. PCH is caused by a biphasic immunoglobulin G antibody that binds...
2.
Gupta D, Arya V, Dass J, Gupta N, Kalra M, Sachdeva A, et al.
Blood Res . 2024 May; 59(1):19. PMID: 38743166
Background: Hemophilia A (HA) is an X-linked inherited bleeding disorder caused by reduced factor VIII (FVIII) levels. Approximately 10-15% of patients with severe HA (SHA) do not present with the...
3.
Selvaraj H, Sachdeva A, Kalra M
Pediatr Blood Cancer . 2024 Jan; 71(4):e30897. PMID: 38291800
No abstract available.
4.
Bhayana S, Kalra M, Sachdeva P, Sachdev A, Sachdeva A
Indian J Crit Care Med . 2022 Jul; 26(6):733-735. PMID: 35836624
How To Cite This Article: Bhayana S, Kalra M, Sachdeva P, Sachdev A, Sachdeva A. Unique Challenges Faced by a Child with Standard Risk Leukemia in Post-COVID Era: A Case...
5.
Dinand V, Sachdeva A, Sharma S, Prasad A, Pant D, Sachdev A, et al.
Indian J Med Res . 2022 Jun; 154(6):843-848. PMID: 35662089
Background & Objectives: Elevated soluble interleukin-2 receptor (sIL2R) is a diagnostic criterion for haemophagocytic lymphohistiocytosis (HLH). International guidelines propose a 2400 U/ml cut-off or individual laboratory-defined cut-off. However, sIL2R normal...
6.
Mareddy C, Kalra M, Sachdeva A
Br J Haematol . 2022 Apr; 197(5):618-626. PMID: 35467751
Thrombopoietin receptor agonists are important therapeutic option in children with immune thrombocytopenia (ITP). We evaluated the response, efficacy, safety of a generic form of romiplostim manufactured in India for treating...
7.
Danewa A, Kalra M, Sachdeva A, Sachdeva P, Bansal D, Bhat S, et al.
Indian Pediatr . 2022 Feb; 59(6):467-475. PMID: 35105820
Justification: In India, there is a lack of uniformity of treatment strategies for aplastic anemia (AA), and many children are managed only with supportive care due to non-availability of hematopoietic...
8.
Paul T, Kalra M, Danewa A, Sachdeva P, Thatikonda K, Sachdeva D, et al.
Indian Pediatr . 2021 May; 59(4):283-286. PMID: 34016798
Objective: To describe the epidemiological features, outcomes and prognostic factors in diagnosis of pediatric hemophagocytic lymphohistiocytosis (HLH). Methods: 118 children fulfilling the inclusion criteria for HLH were identified from review...
9.
Rawat A, Vignesh P, Sudhakar M, Sharma M, Suri D, Jindal A, et al.
Front Immunol . 2021 Mar; 12:625320. PMID: 33717137
Background: Chronic granulomatous disease (CGD) is an inherited defect in phagocytic respiratory burst that results in severe and life-threatening infections in affected children. Single center studies from India have shown...
10.
Thatikonda K, Kalra M, Danewa A, Sachdeva P, Paul T, Sachdeva D, et al.
Indian Pediatr . 2021 Feb; 58(8):737-740. PMID: 33634793
Objective: To analyze clinical and laboratory parameters, and treatment outcomes of children with autoimmune hemolytic anemia (AIHA). Methods: Retrospective analysis of 50 children aged 0-18 years. Monospecific direct antiglobulin test...